A proteomic approach for the diagnosis of bacterial meningitis

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Jesse, Sarah ^a   Steinacker, Petra ^a   Lehnert, Stefan ^a   Sdzuj, Martin ^a   Cepek, Lukas ^a   Tumani, Hayrettin ^a   Jahn, Olaf ^c,d   Schmidt, Holger ^b   Otto, Markus ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c Deutsche Forschungsgemeinschaft   (Germany)

^d MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; AMYLOID PRECURSOR PROTEIN ALPHA; APOLIPOPROTEIN E; FIBRINOGEN; FIBRINOGEN BETA CHAIN; FIBULIN; FIBULIN 1; GLIAL FIBRILLARY ACIDIC PROTEIN; HAPTOGLOBIN; PROSTAGLANDIN D SYNTHASE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; PROTEIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID FLOW; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEOMICS; RELIABILITY; TWO DIMENSIONAL GEL ELECTROPHORESIS; VALIDATION PROCESS; VIRUS MENINGITIS; WESTERN BLOTTING; CEREBROSPINAL FLUID; CHEMISTRY; METHODOLOGY; VALIDATION STUDY;

BACTERIA (MICROORGANISMS);

AMYLOID BETA-PROTEIN PRECURSOR; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; CEREBROSPINAL FLUID; DIAGNOSIS, DIFFERENTIAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MENINGITIS, BACTERIAL; MENINGITIS, VIRAL; PROTEINS; PROTEOMICS;

EID: 77956310654     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010079     Document Type: Article

References (50)

1. Rasmussen HH, Sorensen HT, Moller-Petersen J, Mortensen FV, Nielsen B (1992) Bacterial meningitis in elderly patients: clinical picture and course. Age Ageing 21: 216-220.
2. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, et al. (2004) Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351: 1849-1859.
3. Pena JA, Jimenez L (1999) [Prognosis of bacterial meningitis]. Rev Neurol 29: 311-315.
4. Karandanis D, Shulman JA (1976) Recent survey of infectious meningitis in adults: review of laboratory findings in bacterial, tuberculous, and aseptic meningitis. South Med J 69: 449-457.
5. Deisenhammer F, Bartos A, Egg R, Gilhus NE, Giovannoni G, et al. (2006) Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol 13: 913-922.
6. Berg B, Gardsell P, Skansberg P (1982) Cerebrospinal fluid lactate in the diagnosis of meningitis. Diagnostic value compared to standard biochemical methods. Scand J Infect Dis 14: 111-115.
7. Hansson LO, Axelsson G, Linne T, Aurelius E, Lindquist L (1993) Serum Creactive protein in the differential diagnosis of acute meningitis. Scand J Infect Dis 25: 625-630.
8. Coll MT, Uriz MS, Pineda V, Fontanals D, Bella F, et al. (1994) Meningococcal meningitis with 'normal' cerebrospinal fluid. J Infect 29: 289-294.
9. Onorato IM, Wormser GP, Nicholas P (1980) 'Normal' CSF in bacterial meningitis. JAMA 244: 1469-1471.
10. Polk DB, Steele RW (1987) Bacterial meningitis presenting with normal cerebrospinal fluid. Pediatr Infect Dis J 6: 1040-1042.
11. Heckenberg SG, de Gans J, Brouwer MC, Weisfelt M, Piet JR, et al. (2008) Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore) 87: 185-192.
12. Brechlin P, Jahn O, Steinacker P, Cepek L, Kratzin H, et al. (2008) Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease. Proteomics 8: 4357-4366.
13. Hu Y, Malone JP, Fagan AM, Townsend RR, Holtzman DM (2005) Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid. Mol Cell Proteomics 4: 2000-2009.
14. Tastet C, Lescuyer P, Diemer H, Luche S, van Dorsselaer A, et al. (2003) A versatile electrophoresis system for the analysis of high- and low-molecularweight proteins. Electrophoresis 24: 1787-1794.
15. Tumani H, Nau R, Felgenhauer K (1998) Beta-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases. Ann Neurol 44: 882-889.
16. Tumani H, Reiber H, Nau R, Prange HW, Kauffmann K, et al. (1998) Betatrace protein concentration in cerebrospinal fluid is decreased in patients with bacterial meningitis. Neurosci Lett 242: 5-8.
17. Noris-Garcia E, Dorta-Contreras AJ, Gonzalez-Hernandez M, Bu Coifu-Fanego R, Padron-Gutierrez D, et al. (2008) [Clinical relevance of haptoglobin/IgG index and Boyer's score to the differential diagnosis of bacterial and viral meningitis]. Rev Neurol 47: 394-398.
18. Storey E, Cappai R (1999) The amyloid precursor protein of Alzheimer's disease and the Abeta peptide. Neuropathol Appl Neurobiol 25: 81-97
19. Ohsawa I, Takamura C, Kohsaka S (2001) Fibulin-1 binds the amino-terminal head of beta-amyloid precursor protein and modulates its physiological function. J Neurochem 76: 1411-1420.
20. Lewczuk P, Hornegger J, Zimmermann R, Otto M, Wiltfang J, et al. (2008) Neurochemical dementia diagnostics: assays in CSF and blood. Eur Arch Psychiatry Clin Neurosci 258 Suppl 5: 44-49.
21. Ray P, Badarou-Acossi G, Viallon A, Boutoille D, Arthaud M, et al. (2007) Accuracy of the cerebrospinal fluid results to differentiate bacterial from non bacterial meningitis, in case of negative gram-stained smear. Am J Emerg Med 25: 179-184.
22. Felgenhauer K, Kober D (1985) Apurulent bacterial meningitis (compartmental leucopenia in purulent meningitis). J Neurol 232: 157-161
23. Powers WJ (1985) Cerebrospinal fluid lymphocytosis in acute bacterial meningitis. Am J Med 79: 216-220.
24. Cunha BA (2006) Distinguishing bacterial from viral meningitis: the critical importance of the CSF lactic acid levels. Intensive Care Med 32: 1272-1273; author reply 1274.
25. Tankhiwale SS, Jagtap PM, Khadse RK, Jalgaonkar SV (2001) Bacteriological study of pyogenic meningitis with special reference to C-reactive protein. Indian J Med Microbiol 19: 159-160.
26. Paradowski M, Lobos M, Kuydowicz J, Krakowiak M, Kubasiewicz-Ujma B (1995) Acute phase proteins in serum and cerebrospinal fluid in the course of bacterial meningitis. Clin Biochem 28: 459-466.
27. Boving MK, Pedersen LN, Moller JK (2009) Eight-plex PCR and liquid-array detection of bacterial and viral pathogens in cerebrospinal fluid from patients with suspected meningitis. J Clin Microbiol 47: 908-913.
28. Chakrabarti P, Das BK, Kapil A (2009) Application of 16S rDNA based seminested PCR for diagnosis of acute bacterial meningitis. Indian J Med Res 129: 182-188.
29. Del Prete R, Di Taranto AM, Lipsi MR, Natalicchio MI, Antonetti R, et al. (2009) Simultaneous detection of viruses and Toxoplasma gondii in cerebrospinal fluid specimens by multiplex polymerase chain reaction-based reverse hybridization assay. New Microbiol 32: 143-146.
30. Reiber H (2001) Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta 310: 173-186
31. Reiber H (2003) Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci 21: 79-96.
32. Otto M, Lewczuk P, Wiltfang J (2008) Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases. Methods 44: 289-298.
33. Sjogren M, Gisslen M, Vanmechelen E, Blennow K (2001) Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment. Neurosci Lett 314: 33-36.
34. Olsson A, Hoglund K, Sjogren M, Andreasen N, Minthon L, et al. (2003) Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients. Exp Neurol 183: 74-80.
35. Mattsson N, Axelsson M, Haghighi S, Malmestrom C, Wu G, et al. (2009) Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis. Mult Scler 15: 448-454.
36. Weber JR, Tuomanen EI (2007) Cellular damage in bacterial meningitis: an interplay of bacterial and host driven toxicity. J Neuroimmunol 184: 45-52.
37. Zhu H, Dahlstrom A (2007) Glial fibrillary acidic protein-expressing cells in the neurogenic regions in normal and injured adult brains. J Neurosci Res 85: 2783-2792.
38. Linker RA, Brechlin P, Jesse S, Steinacker P, Lee DH, et al. (2009) Proteome profiling in murine models of multiple sclerosis: identification of stage specific markers and culprits for tissue damage. PLoS One 4: e7624.
39. Brettschneider J, Tumani H, Kiechle U, Muche R, Richards G, et al. (2009) IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome. PLoS One 4: e7638.
40. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, et al. (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155: 853-862.
41. Naylor R, Hill AF, Barnham KJ (2008) Is covalently crosslinked Abeta responsible for synaptotoxicity in Alzheimer's disease? Curr Alzheimer Res 5: 533-539.
42. Rao KS, Hegde ML, Anitha S, Musicco M, Zucca FA, et al. (2006) Amyloid beta and neuromelanin-toxic or protective molecules? The cellular context makes the difference. Prog Neurobiol 78: 364-373.
43. Van de Beek D, de Gans J, Spanjaard L, et al. (2004a) Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351: 1849-1859.
44. MiQ K, E, Dörries R, Geiß HK, Matz B, Neumann-Häfelin D, Pfister HW, Prange H, Schlü ter D, Spellerberg B, Spencker FB (2001) Qualitä tsstandards in der mikrobiologisch-infektiologischen Diagnostik. Infektionen des Zentralnervensystems. Urban & Fischer, München.
45. Alban A, David SO, Bjorkesten L, Andersson C, Sloge E, et al. (2003) A novel experimental design for comparative two-dimensional gel analysis: twodimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3: 36-44.
46. Jahn O, Hesse D, Reinelt M, Kratzin HD (2006) Technical innovations for the automated identification of gel-separated proteins by MALDI-TOF mass spectrometry. Anal Bioanal Chem 386: 92-103.
47. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
48. Wiltfang J, Smirnov A, Schnierstein B, Kelemen G, Matthies U, et al. (1997) Improved electrophoretic separation and immunoblotting of beta-amyloid (A beta) peptides 1-40, 1-42, and 1-43. Electrophoresis 18: 527-532.
49. Jesse S, Steinacker P, Cepek L, von Arnim CA, Tumani H, et al. (2009) Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease. J Alzheimers Dis 17: 541-551.
50. Steinacker P, Hendrich C, Sperfeld AD, Jesse S, Lehnert S, et al. (2009) Concentrations of beta-amyloid precursor protein processing products in cerebrospinal fluid of patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration. J Neural Transm 116: 1169-1178.